Welcome to 0uCE, the unCommon Era

Using the best available technologies to efficiently build drugs that target the underlying cause of rare uncommon diseases.

First target: RETT Syndrome

Neurodevelopmental monogenetic disease that impacts 1 in 10,000 girls

Our deep expertise in this disease has allowed us to identify multiple therapeutics that could improve the phenotype and in combination could deliver a cure.